Stereotactic Body Radiation Therapy (SBRT) to Extend the Benefit of Systemic Therapy in Patients With Solitary Disease Progression
This study is testing if using highly focused radiation, called SBRT, can help stop breast cancer from growing in patients who have cancer that has spread to only a few areas. By adding this targeted treatment to your current medication, researchers hope to keep the cancer under control for a longer period of time.
This study is for adults over 18 with metastatic breast cancer that has spread to only a few small areas. You must have specific cancer types, such as HER2-positive breast cancer or hormone receptor-positive/HER2-negative breast cancer, to be eligible.
You will continue taking your regular breast cancer medication while also receiving SBRT, which is a form of radiation therapy that delivers high, precise doses to one specific tumor site. Your medical team will monitor you closely throughout the process to ensure you are doing well.
The study is currently recruiting patients at three locations in New Jersey: Basking Ridge, Middletown, and Montvale. Please check with your doctor to see if these sites are a convenient option for your care.
- 1You stay on your current cancer medication while adding this focused radiation treatment.
- 2The goal is to prevent cancer from spreading further or growing in other parts of your body.
- 3You cannot participate if your cancer has spread to the brain or if you have already had radiation in the same area.
No related links yet
Seen this study covered in the news, or found a page that explains it well? Send it over and we'll review it.
Suggest a linkThis summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.